New diagnostic service launched to treat prostate cancer

News Network
September 18, 2020

cancer.JPG

Ludhiana, Sept 18: DMCH Cancer Care Centre in collaboration with American Oncology Institute recently started a new diagnostic service (PSMA-PET Scan) in treating various prostate cancer.

Prostate cancer is the most common cancer in men and one of the leading causes of cancer death. Prostate Specific Membrane Antigen (PSMA ) is highly expressed in prostate cancer and its expression increases with tumour aggressiveness, metastatic disease and disease recurrence.

Secretary of DMCH Managing Society, Sh. Prem Kumar Gupta said, “Very few facilities in the region have this state-of-art facility and will be of great benefit for the patients.” He further added, “DMCH Cancer Care Centre is always in the process of acquiring new techniques and facilities for diagnosing and treating various cancer diseases. The availability of this facility will go a long way to help both patients and clinicians in knowing about the proper stage of prostate cancer, thereby helping patients with better outcome.”

Dr. Puneet Bhutani from the Department of Nuclear Medicine, American Oncology Institute stated, “This is a major milestone in diagnosis of prostate cancer. The procedure of diagnosing prostate cancer through PSMA-PET Scan is more accurate method for early detection of recurrent disease. It allows the oncologists to treat patients at an early stage and provide them a better treatment outcome.”

About American Oncology Institute:

American Oncology Institute is the leading cancer care provider across South Asia operating a chain of cancer hospitals in multiple cities across South Asia. AOI today is a wholly owned subsidiary of Varian Medical Systems (NYSE: VAR).

The team of clinical, paraclinical and healthcare operations experts pride themselves with the aim of closing the gap between standards of cancer care in South Asia and the developed cancer hospitals in the West. AOI provides comprehensive cancer management that is powered by clinical excellence, world class technology as well as best in class clinical pathways and protocols for treatment planning and execution, providing best in-class quality in cancer care across South Asia.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
October 13,2020

New Brunswick, Oct 13: A late-stage study of Johnson & Johnson's COVID-19 vaccine candidate has been paused while the company investigates whether a study participant's unexplained illness is related to the shot.

The company said in a statement on Monday evening that illnesses, accidents and other so-called adverse events are an expected part of any clinical study, especially large studies, but that its physicians and a safety monitoring panel would try to determine what might have caused the illness.

The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the US.

The company declined to reveal any more details about the illness, citing the participant's privacy.

Temporary stoppages of large medical studies are relatively common. Few are made public in typical drug trials, but the work to make a coronavirus vaccine has raised the stakes on these kinds of complications.

Companies are required to investigate any serious or unexpected reaction that occurs during drug testing. Given that such tests are done on tens of thousands of people, some medical problems are a coincidence. In fact, one of the first steps the company said it will take is to determine if the person received the vaccine or a placebo.

The halt was first reported by the health news site STAT.

Final-stage testing of a vaccine made by AstraZeneca and Oxford University remains on hold in the US as officials examine whether an illness in its trial poses a safety risk. That trial was stopped when a woman developed severe neurological symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, the company has said. That company's testing has restarted elsewhere.

Johnson & Johnson was aiming to enroll 60,000 volunteers to prove if its single-dose approach is safe and protects against the coronavirus. Other vaccine candidates in the US require two shots.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
October 24,2020

Washington, Oct 24: The initial phase of the COVID-19 lockdown, which was imposed through March and April in several countries, may have dramatically altered people's personal eating and sleeping habits, according to a new study based on a first-of-its-kind global survey.

The study, published in the journal Obesity, evaluated the inadvertent changes in health behaviours that took place under the pandemic's widespread restrictions.

According to the survey, conducted by the researchers, including those from Louisiana State University (LSU) in the US, the lockdown's effects were magnified among people with obesity.

"The stay-at-home orders did result in one major health positive. Overall, healthy eating increased because we ate out less frequently. However, we snacked more. We got less exercise. We went to bed later and slept more poorly. Our anxiety levels doubled," said study co-author Leanne Redman from Louisiana State University.

"Overall, people with obesity improved their diets the most. But they also experienced the sharpest declines in mental health and the highest incidence of weight gain," Redman said.

The survey ran during the month of April and included responses from 7,754 people and the majority of the respondents were in the US with residents of Australia, Canada, the UK, and more than 50 other countries also participating.

It revealed that about one-third of surveyed people with obesity gained weight during the lockdown, compared to 20.5 percent of people with normal weight or overweight.

"This study is the first to survey thousands of people across the globe on lifestyle behaviour changes in response to stay-at-home orders. The study demonstrates that chronic diseases like obesity affect our health beyond the physical," said John Kirwan, another co-author of the study.

The scientists believe physicians and scientists should modify the way they manage patients with obesity in two ways.

One of these methods is by increasing the number of mental health screenings during and after the pandemic, said Emily Flanagan, lead author of the study from LSU.

Flanagan said physicians should also monitor patients by remaining connected to the study participants through remote visits and telehealth to prevent irreversible health effects from the pandemic.

The scientists believe virtual visits via telehealth checkups can assuage patients' concerns about the safety of in-person visits.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
October 13,2020

New Delhi, Oct 13: The World Health Organization has debunked the idea of herd immunity, saying it is 'scientifically and ethically problematic' and is not an option.

There are some who say the coronavirus be allowed to spread naturally in the lack of a vaccine to achieve immunity in a community.

Herd immunity is achieved by protecting people from a virus not by exposing them to it, said WHO Director General Tedros Ghbreseysus.

"Allowing a dangerous virus that we don't fully understand to run free is unethical. It is not a option," Tedros said in a statement on Monday.

Medical journal Lancet also warned that exposure to the virus does not guarantee future immunity. The second infection may come with more severe symptoms.

The Covid-19 virus has claimed one million lives and still spreading across the world. And there is no vaccine available right now.

Tedros made the comments in the context of China which is preparing to test an entire population of the eastern city Qingdao this week.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.